#USA #Grapevine #Thermal Imaging #MolecuLight #DX Platform

MolecuLight Launches Groundbreaking Thermal Imaging for DX™ Platform

MolecuLight Inc., a global leader in fluorescence imaging at the point of care for rapid detection of wound-infection bacteria, has unveiled its innovative thermal imaging module for the MolecuLightDX™ platform. This new clip-on module enables clinicians to simultaneously capture informative thermal images along with established fluorescence images that evaluate bacterial load and standard images for precise wound measurement. This all-in-one tool significantly enhances wound assessment by integrating multiple imaging modalities into a single device.

The introduction of this module coincides with MolecuLight’s substantial presence at the upcoming Symposium on Advanced Wound Care (SAWC) Spring meeting scheduled from April 30 to May 3, 2025, in Grapevine, Texas, where the company will exhibit at Booth 633 and present compelling clinical evidence supporting its imaging platform.

At the SAWC Spring meeting, MolecuLight will showcase over ten posters that illustrate the transformative power of its fluorescence imaging technology, thermal imaging, and wound measurement innovations. These presentations will emphasize key themes such as enhancing wound assessment through accurate bacterial detection, revolutionizing management of complex surgical wound reconstructions, and advocating a holistic evaluation approach by integrating fluorescence imaging with thermal imaging modalities. Notable contributors to this research include experts such as Drs. Michael Desvigne, Charles Andersen, Alisha Oropallo, and Misael Alonso, who will reinforce the critical role of this technology in diverse wound care settings.

One compelling application of the thermal imaging approach is its recognition within the wound care sector for providing insights into localized skin temperature variations. These variations can signal inflammatory or infectious dynamics, perfusion changes, or potential deep tissue damage in early stages, as suggested by clinical literature. The MolecuLight thermal imaging module allows clinicians to visualize, document, and quantify these temperature changes directly at the patient’s bedside, complementing the existing capabilities of the DX platform.

By seamlessly integrating thermal data with bacterial load information (obtained via fluorescence imaging) and accurate digital wound measurements all on the DX platform, clinicians gain a more comprehensive and objective understanding of the wound environment. This powerful combination not only facilitates more informed treatment decisions but also enhances workflow efficiency and healing progression monitoring.

Key Features and Benefits of the MolecuLightDX™ Integrated with Thermal Imaging Module

• - All-in-One Comprehensive Assessment: Capture and correlate thermal, fluorescence (bacterial load), and standard images using a single device at the point of care.
• - Objective Temperature Analysis: Quickly visualize skin temperature distribution and quantify temperature differences between two anatomical sites.
• - Streamlined Workflow and Documentation: Capture thermal, fluorescence, and standard images in a single click, improving efficiency and creating a visual documentation record compatible with existing EHR integration pathways.
• - Enhanced Clinical Insight: Combine objective data on wound size, bacterial presence, and thermal activity for better treatment planning and monitoring.

Anil Amlani, CEO of MolecuLight, remarked, "We continue to push the boundaries of diagnostic imaging in wound treatment, and this launch marks a significant advancement. Clinicians can access critical information from three essential assessment modalities for the first time—precise digital wound measurement, validated bacterial fluorescence imaging, and informative thermal imaging—all seamlessly integrated in one portable device. This powerful multimodal capability offers a truly comprehensive view of the wound environment at the point of care, empowering clinicians with unprecedented insights for more effective, data-driven treatment decisions and enhanced wound healing tracking."

Availability

The MolecuLight thermal imaging module is now available in North America for the MolecuLightDX™ platform. MolecuLight will demonstrate this new all-in-one capability at the SAWC Spring meeting in Grapevine, Texas, at Booth 633, from April 30 to May 3, 2025.

About MolecuLight Inc.

MolecuLight Inc. is a world-leading private medical imaging company that manufactures and markets the MolecuLight iX® and DX™ wound imaging devices. These are the only FDA-approved class II imaging devices for real-time detection of high bacterial loads in wounds, providing accurate digital wound measurements for comprehensive wound management, with robust clinical evidence supporting over 100 peer-reviewed publications.